| Increased oxidative stress and hypozincemia in male obesity M Ozata, M Mergen, C Oktenli, A Aydin, SY Sanisoglu, E Bolu, MI Yilmaz, ... Clinical biochemistry 35 (8), 627-631, 2002 | 427 | 2002 |
| The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine MI Yilmaz, M Saglam, K Caglar, E Cakir, A Sonmez, T Ozgurtas, A Aydin, ... American Journal of Kidney Diseases 47 (1), 42-50, 2006 | 371 | 2006 |
| Prostate cancer and adiponectin S Goktas, MI Yilmaz, K Caglar, A Sonmez, S Kilic, S Bedir Urology 65 (6), 1168-1172, 2005 | 367 | 2005 |
| Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance T Dogru, A Sonmez, I Tasci, E Bozoglu, MI Yilmaz, H Genc, G Erdem, ... Diabetes research and clinical practice 76 (1), 24-29, 2007 | 364 | 2007 |
| Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients T Celik, A Iyisoy, H Kursaklioglu, E Kardesoglu, S Kilic, H Turhan, ... Journal of hypertension 24 (3), 591-596, 2006 | 323 | 2006 |
| Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma AL Gomes, A Teijeiro, S Burén, KS Tummala, M Yilmaz, A Waisman, ... Cancer cell 30 (1), 161-175, 2016 | 292 | 2016 |
| Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease M Kanbay, Y Solak, HU Unal, YG Kurt, M Gok, H Cetinkaya, M Karaman, ... International urology and nephrology 46, 1619-1625, 2014 | 274 | 2014 |
| Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease JJ Carrero, AR Qureshi, J Axelsson, MI Yilmaz, S Rehnmark, MR Witt, ... Journal of internal medicine 262 (6), 690-701, 2007 | 251 | 2007 |
| FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, E Demirkaya, ... Kidney international 78 (7), 679-685, 2010 | 218 | 2010 |
| Leptin influences cellular differentiation and progression in prostate cancer K Saglam, E Aydur, MI Yilmaz, S Goktas Journal of Urology 169 (4), 1308-1311, 2003 | 194 | 2003 |
| Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin MI Yilmaz, M Saglam, AR Qureshi, JJ Carrero, K Caglar, T Eyileten, ... Nephrology Dialysis Transplantation 23 (5), 1621-1627, 2008 | 187 | 2008 |
| Serum visfatin concentration and endothelial dysfunction in chronic kidney disease MI Yilmaz, M Saglam, JJ Carrero, AR Qureshi, K Caglar, T Eyileten, ... Nephrology Dialysis Transplantation 23 (3), 959-965, 2008 | 185 | 2008 |
| Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial MI Yilmaz, A Sonmez, M Saglam, H Yaman, S Kilic, T Eyileten, K Caglar, ... American journal of kidney diseases 59 (2), 177-185, 2012 | 178 | 2012 |
| Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage KS Tummala, AL Gomes, M Yilmaz, O Graña, L Bakiri, I Ruppen, ... Cancer cell 26 (6), 826-839, 2014 | 175 | 2014 |
| Serum sIL-2r, IL-6, IL-10 and TNF-α level in familial Mediterranean fever patients Y Baykal, K Saglam, MI Yilmaz, A Taslipinar, SB Akinci, A Inal Clinical rheumatology 22, 99-101, 2003 | 162 | 2003 |
| Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease ME Suliman, MI Yilmaz, JJ Carrero, AR Qureshi, M Saglam, OM Ipcioglu, ... Clinical Journal of the American Society of Nephrology 3 (4), 976-985, 2008 | 152 | 2008 |
| Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease MI Yilmaz, D Siriopol, M Saglam, YG Kurt, HU Unal, T Eyileten, M Gok, ... Kidney international 86 (6), 1213-1220, 2014 | 151 | 2014 |
| Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients M Kanbay, MI Yilmaz, M Apetrii, M Saglam, H Yaman, HU Unal, M Gok, ... American journal of nephrology 36 (3), 228-237, 2012 | 150 | 2012 |
| Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients K Caglar, MI Yilmaz, M Saglam, E Cakir, C Acikel, T Eyileten, M Yenicesu, ... Clinical Journal of the American Society of Nephrology 3 (1), 61-68, 2008 | 145 | 2008 |
| Cytokine dysregulation in chronic kidney disease: how can we treat it? JJ Carrero, MI Yilmaz, B Lindholm, P Stenvinkel Blood purification 26 (3), 291-299, 2008 | 144 | 2008 |
Alper SonmezAnkara Guven HospitalVerified email at guven.com.tr
